Memorion (Donepezil Hydrochloride)

Donepezil Hydrochloride works by reversibly inhibiting the enzyme acetylcholinesterase, which breaks down acetylcholine. By blocking this enzyme, the drug raises acetylcholine levels at synapses, supporting the neural pathways that are deficient in Alzheimer’s and Parkinson’s‑related dementia.

The dose of Memorion is individualized by the prescribing clinician based on the patient’s condition, tolerability, and response. Typical regimens start with a low dose that may be titrated upward, but exact dosing must be determined by a qualified health professional.

Safety data for Donepezil Hydrochloride in pregnancy and lactation are limited. The product should be avoided unless the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Memorion, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memorion (Donepezil) is a once‑daily, reversible acetylcholinesterase inhibitor with a relatively long half‑life, allowing steady plasma levels. Compared with rivastigmine or galantamine, it often requires fewer dose adjustments and has a simpler titration schedule, though individual response and tolerability vary.

Memorion should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Memorion is taken orally, usually once daily, with or without food. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed by a healthcare professional.

Serious adverse events include significant bradycardia, syncope, severe liver enzyme elevations, and rare cases of seizures or life‑threatening skin reactions. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat changes, jaundice, or severe rash.

Memorion is contraindicated in individuals with known hypersensitivity to Donepezil or any excipients, those with severe cardiac conduction disorders (e.g., sick‑sinus syndrome without a pacemaker), and patients with a history of serious adverse reactions to cholinesterase inhibitors.